INTRODUCTION
undergoing laparoscopic cholecystectomy.
MATERIALS AND METHODS
This study was a prospective, randomized double blind clinical study and was performed after ethical approval from BPKIHS, Institutional Ethical Review Board (IERB). Eighty four American Society of Anaesthesiologist physical status (ASA PS) I and II between 18-60 years, of either sex and posted for laparoscopic cholecystectomy under general anaesthesia who gave informed written consent were included in the study. Patients with ASA PS III or more with neurological and psychiatric disorder, known allergy, liver and renal diseases, heart rate (HR) <60bpm, mean arterial pressure (MAP) <70mm of Hg, duration of laryngoscopy and intubation more than 15 seconds were excluded. The patients were randomly allocated by computer generated random numbers into two groups of 42 each, Group S (patients receiving dexmedetomidine 0.25ml/kg (1µg/kg) intravenously(IV) over 10 minutes before induction then 0.1ml/kg/hr(0.4µg/kg/hr) IV, till removal of gall bladder) and Group C (patient receiving similar volume of Normal saline). Infusate was prepared according to the group allotted by anaesthesia assistant not involved in the study. To prepare the infusate, dexmedetomidine 0.5ml containing 50 µg of the drug was withdrawn in a 20ml syringe and diluted to 12.5ml with normal saline resulting in the final concentration of 4µg/ml. Similar volume of normal saline infusion by syringe pump was prepared for Group C. The syringe pump was set and covered with a green cloth. Thus, the anaesthesiologist involved in monitoring and the patient were unaware of the group. The data was decoded only at the time of tabulation and analysis. All patients were premedicated with tab alprazolam 0.5mg on the night before and 2 hours before the surgery. On the operation table, a multiparameter monitor was attached and the baseline HR, MAP, blood pressure and oxygen saturation (SPO2) were noted. 18G Intravenous (IV) cannula was inserted for giving the IV fluids and drugs. Injection granisetron 1mg was given IV. 10minutes after starting the drug infusion at 1µg/kg (0.25ml/kg), infusion rate was changed to 0.4µg/kg/ hr(0.1ml/kg/hr) and preoxygenation was performed for 3 minutes. Patients were induced with fentanyl 1.5µg/kg, IV propofol till the loss of verbal command, followed by 0.1mg/kg of injection vercuronium bromide and trachea was intubated. Anaesthesia was maintained with isoflurane in oxygen. Intra-abdominal pressure was maintained between 12 to 14 mm Hg. End tidal carbon dioxide was kept between 35 to 45mm Hg. Injection 0.25% plain bupivacaine 20ml intraperitoneal and 10ml skin infiltration was given in all the patients. Conventional way of reversal and extubation were followed. HR, systolic blood pressure(SBP), diastolic blood pressure(DBP), MAP and SpO2 were recorded before induction, one minute after intubation, two minutes, five minutes and every five minutes thereafter till the end of surgery and 5 , 10, 20 and 30 mins postoperatively. Patients were also observed for postoperative sedation level, effective analgesia (time from completion of surgery to the first dose of rescue analgesia, when VAS>4 [visual analogue scale]), total amount of analgesic drug required during the first 24 hours postoperatively and the adverse effects. Injection diclofenac sodium 75mg IM was given if VAS 4 to 6 and injection tramadol 50mg IV if VAS score >6. Degree of sedation was assessed using Ramsay Sedation Score at 45mins, 60mins and every 30 minutes till 300mins, postoperatively or till the patient was awake and conscious. Throughout the study, patients were observed for any adverse effects like bradycardia, tachycardia (fall of heart rate less than or more than 20% from the base line, respectively), hyper or hypotension (MAP more than or less than 20% of preoperative level, respectively) or any other complication and managed accordingly. According to an article, 2 P1=0.05 and P2=0.35 (where P1 and P2 is the proportion of tachycardia in Normal saline group and intravenous Dex 0.2 group respectively). Using the two sample proportion test, 95%CI and 90% Power, the resulted sample size was 36 in each arm. We included 42 patients in each group to allow for dropouts. The collected data were entered in MS Excel 2007 and converted into SPSS software version 20.0 for statistical analysis. For descriptive statistics mean, standard deviation, proportion percentage was calculated. For inferential statistics chi square test , Independent T test or Mann-Whitney U-Test was applied to find out the significant difference between Group S and Group C with other related variable at 95% CI where p=0.05.
RESULTS
Demographic variables, duration of surgery and anaesthesia between the two groups were comparable (Table 1) .
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Baseline HR and MAP were comparable in both the groups. Mean HR was significantly lower in Group S than Group C at most of the times of observation, intraoperatively ( Figure 1 ). Mean MAP was significantly lower in Group S at 25, 30 and 55 minutes intervals, intraoperatively (Figure 2 ). Effective analgesia (time from completion of surgery to first dose of rescue analgesia, VAS>4) or the time of first rescue analgesia was significantly earlier in Group C than in Group S ( Table 2) .Total analgesia requirement in 24 hours was higher in Group C than Group S (Table 3) . Although total tramadol requirement was comparable in both groups but diclofenac sodium requirement was significantly (P<0.001) higher in Group C. In Group S, 25 patients as compared to 38 patients in Group C, were co-operative, oriented and calm, at 30mins after surgery (Figure 3) . In Group S, 17 patients as compared to 4 patients in Group C, were responsive to commands only, at 30 mins after surgery. In Group S, 11 patients as compared to 4 patients in Group C were co-operative, oriented and calm, at 45 mins after surgery ( figure 3) . In Group S, 7 patients were responsive to commands only whereas in Group C, no patients were responsive to commands only, at 45 mins after surgery. All patients in both the groups became fully awake and conscious at 60 mins. So, further scores were not taken.
14 cases developed hypertension in Group S and 18 in Group C. Hypotension developed in 5 patients in Group S and none in Group C. Occurrence of tachycardia was 10 and 22 in Group S and Group C, respectively. There were 13 cases of bradycardia in Group S whereas 2 in Group C. One of the patient in Group S developed bronchospasm just before extubation. Some of these effects are related to increased intraabdominal pressure. Immediately, after pneumoperitonium, plasma level of norepinephrine, epinephrine and plasma renin activity increases. 6 The renin-angiotensin-aldosterone-system is also activated by the increased catecholamine level. Altogether contributing to elevated arterial pressure, increased systemic and pulmonary vascular resistance and reduced cardiac output. 7 Recently, there is increase in the use of α2 agonist in anaesthesia practice because of their anxiolytic, sedative, sympatholytic and analgesic sparing properties. 8 Dexmedetomidine is a highly selective α2 adrenergic agonist. It acts through three types of α2 receptors-α2A, α2B and α2C situated in brain and spinal cord. The action includes sedation, anxiolysis, analgesia and sympatholysis, the latter leading to hypotension and bradycardia. Activation of α2A receptors in brain stem vasomotor centre results in suppression of norepinephrine release and causes hypotension and bradycardia. Stimulation of α2A and α2C in locus ceruleus causes sedation. In the spinal cord, activation of both α2A and α2C receptors directly reduce pain transmission by reducing release of substance P. Considering these properties, many researches are performed to assess its effect on haemodynamics in patients undergoing laparoscopic surgeries. With higher dose infusion of dexmedetomidine , high incidence of adverse cardiac effects have been observed. 9 In low dose, dexmedetomidine exhibits linear kinetics, meaning that a constant amount of drug is eliminated per hour rather than a constant fraction of drug. Hence in the current study, we used low dose of 0.4µg/kg/hr dexmedetomidine infusion after a loading dose of 1µg/kg over 10 minutes. In our study, after dexmedetomidine infusion of loading dose of 1µg/kg, HR decreased significantly from the baseline. There were no changes in HR and MAP in the normal saline group. Activation of α2 adrenoceptors on vascular smooth muscle is thought to result in vasoconstriction, increased blood pressure and probable reflex decreased heart rate. 10 In our study, there was decrease in both the heart rate and blood pressure during the bolus infusions, however, the decrease in MAP was not significant. This suggests that initial 1µg /kg loading infusion for 10mins is not rapid and may cause minimal increase in blood concentrations of dexmedetomidine. This finding is similar to other studies. 2, 11 In contrast to our study, in a study, 12 there was no difference in baseline and before induction value of HR . The reason could be because of lower dose (0.2µg/kg/hr) of dexmedetomidine infusion used, as compared to our study.
DISCUSSION
In our study, all tracheal intubation were performed by the same anaesthesiologist. There was significant decrease in HR (8.65%) from baseline to one minute after intubation values in dexmedetomidine group. There was no significant difference in MAP in dexmedetomidine group. The use of intraoperative demedetomidine may increase hemodynamic stability because of attenuation of the stress induced sympathoadrenal responses to intubation and during surgery. 13 This finding was also seen in a study, 12 in which at 1min postintubation, the MAP and HR decreased significantly in dexmedetomidine group, 14% and 3% respectively . In a study, 2 at 1min after intubation, there was significant fall in MAP (5.76%) and HR(3.96%) in dexmedetomidine group (0.4µg/kg/hr) but in contrast to our study, there was significant rise in MAP(4.58%) and HR (8.05%) in other dexmedetomidine group (0.2µg/ kg/hr). The reason may be due to low dose of dexmedetomidine. In a similar study, 14 the heart rate and mean blood pressure were found to be low in dexmedetomidine group as compared to normal saline group which was statistically significant after laryngoscopy and intubation. In our study, there were no significant changes in HR and MAP in normal saline group. In a study, 2 contrast to our study, the normal saline group showed significant increase in HR(19.71%) and MAP(15.04%) from the baseline. The reason may be due to use of glycopyrrolate 5µg/kg IM 45mins before induction time. In our study, HR and MAP was found to be decreased in dexmedetomidine group at almost all the intervals compared to NS group (but only change in HR was statistically significant) which was validated by the findings of some other studies. 2, 11, 12, 14 The adverse effects were seen more with dexmedetomidine, however, they were treatable. One case of bronchospasm occurred just before the extubation probably due to light plane of anaesthesia.
Recent studies, not surprisingly, show that intraoperative dexmedetomidine (bolus dose of 0.5-1µg/kg, with or without continuous infusion of 0.5-2µg/kg/hr) causes a significant reduction in the need for both intraoperative and postoperative analgesics in adults. 15 In our study, the pain perception was early in normal saline, postoperatively. Similar inference was made, 2 but the rescue analgesia in dexmedetomidine (0.4µg/kg/ hr) group was at 249 mins. This may be because they used inj. tramadol 1mg/kg IM as premedication. Overall, analgesic requirement in dexmedetomidine group was less than normal saline group. Even if the elimination half -life of dexmedetomidine is short (2-3hrs), the analgesic sparing effect observed after a preoperative or an intraoperative administration usually lasts up to 24 hours , with the anxiolytic, sedative, and thymoanaleptic properties implicated as being partly responsible for this effect. 16, 17 Patients were found significantly sedated among dexmedetomidine group than normal saline group in 30mins in our study but all the patient were cooperative, oriented and calm after 45mins postoperatively. There was better sedation in patients involved in dexmedetomidine (0.4µg/kg/hr and 0.2µg/kg/hr) than in normal saline group in a study, 2 which was similar to our findings.
CONCLUSION
Our study has shown that, dexmedetomidine blunts haemodynamic response to laryngoscopy and tracheal intubation as well as it also improves intraoperative haemodynamic stability, causes postoperative sedation and decreases analgesic requirement. However the sample size was calculated based on heart rate so the power of this study might not be adequate for all primary endpoints which is the limitation of this study. Funding None
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